Skip to main content
. 2018 Apr 20;10(4):678–691. doi: 10.1080/19420862.2018.1452580

Figure 6.

Figure 6.

Inhibition of VEGFR-2 RTK autophosphorylation by ABP 215, bevacizumab (US), and bevacizumab (EU).